CJC Research Applications
CJC-1295 is a synthetic growth hormone releasing hormone (GHRH) analogue peptide developed for laboratory investigations into neuroendocrine mechanisms. This 29-amino acid peptide incorporates strategic amino acid substitutions at positions 2, 8, 15, and 27 compared to native GHRH, enhancing its stability for extended research protocols. Laboratories at Stroid UK Shop frequently investigate this compound’s receptor binding characteristics and downstream signalling pathways in controlled environments.
Research teams examining growth hormone axis modulation utilise this compound to study hypothalamic-pituitary interactions in cellular and tissue models. The peptide’s modified structure demonstrates enhanced resistance to enzymatic degradation compared to endogenous GHRH, making it valuable for time-course studies investigating receptor activation patterns. Investigators working with peptides often compare CJC-1295’s pharmacological profile against native hormone sequences to understand structure-activity relationships.
Laboratory Specifications
| Molecular Weight | 3367.97 g/mol |
|---|---|
| CAS Number | 863288-34-0 |
| Purity | Verify with supplier |
| Storage | -20°C lyophilised powder |
| Form | White lyophilised powder |
| Solubility | Sterile water or bacteriostatic water |
Analytical laboratories studying GHRH receptor pharmacology benefit from this compound’s structural modifications, which confer improved stability during experimental procedures. Research protocols investigating growth hormone secretion patterns frequently incorporate CJC-1295 alongside other compounds from our CJC-1295 peptide collection to examine comparative receptor binding affinities and downstream cellular responses.
Research Storage Protocol
Proper storage conditions are essential for maintaining peptide integrity throughout research investigations. The lyophilised powder should be stored at -20°C in the original sealed vial, protected from moisture and light exposure. Once reconstituted with appropriate sterile diluents, the solution remains stable for laboratory use when maintained at 2-8°C for up to 30 days. Investigators should avoid repeated freeze-thaw cycles to preserve molecular structure. Many research facilities examining SARMs and peptide compounds implement similar storage protocols to ensure experimental reproducibility across multiple assay conditions.
Research Compliance Statement
This CJC-1295 peptide is manufactured by LifeTech Labs exclusively for in-vitro laboratory research applications. This product is not intended for human consumption, therapeutic use, or any clinical applications. Researchers must ensure compliance with institutional guidelines and regulatory requirements when conducting studies involving this compound. All investigations should be performed under appropriate laboratory safety protocols with qualified personnel.
